Literature DB >> 20857253

Shared desmosome gene findings in early and late onset arrhythmogenic right ventricular dysplasia/cardiomyopathy.

Boon Yew Tan1, Rahul Jain, A Dénise den Haan, Yan Chen, Darshan Dalal, Harikrishna Tandri, Nuria Amat-Alarcon, Amy Daly, Crystal Tichnell, Cynthia James, Hugh Calkins, Daniel P Judge.   

Abstract

Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is an inherited form of cardiomyopathy with low penetrance and variable expressivity. Dominant mutations and rare polymorphisms in desmosome genes are frequently identified. We reasoned that individuals with earlier onset disease would have more frequent desmosome gene mutations and rare polymorphisms. Three groups were compared: Young with symptoms attributable to ARVD/C or a diagnosis of ARVD/C at age of 21 years or earlier, Middle with first symptoms or diagnosis age of 22-49 years, and Late with first symptoms or diagnosis at age of 50 or more years. deoxyribonucleic acid (DNA) sequence analysis was performed on five cardiac desmosome genes, and the presence of mutations and rare missense polymorphisms was compared among the three groups. In the entire Young cohort, 20 (67%) had one or more cardiac desmosome gene mutations. The prevalence of cardiac desmosome gene mutations was similar in the Middle (48%) and Late (53%) cohorts (P = 0.23). Similar numbers of individuals in each cohort had more than one desmosome gene mutation, although the numbers are too small for statistical comparisons. The prevalence of certain rare missense DNA variants was not different among the cohorts (P = 0.71), yet these rare missense alleles were more prevalent in the overall study cohort of 112 ARVD/C participants compared to 100 race-matched controls (P = 0.027). The presence of these variants did not associate with the age of onset of ARVD/C or ventricular tachycardia. These findings highlight the complex interplay of environmental and genetic factors contributing to this condition.

Entities:  

Mesh:

Year:  2010        PMID: 20857253      PMCID: PMC3138067          DOI: 10.1007/s12265-010-9224-4

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN: 1937-5387            Impact factor:   4.132


  31 in total

1.  Penetrance of mutations in plakophilin-2 among families with arrhythmogenic right ventricular dysplasia/cardiomyopathy.

Authors:  Darshan Dalal; Cynthia James; Rajiv Devanagondi; Crystal Tichnell; April Tucker; Kalpana Prakasa; Philip J Spevak; David A Bluemke; Theodore Abraham; Stuart D Russell; Hugh Calkins; Daniel P Judge
Journal:  J Am Coll Cardiol       Date:  2006-09-12       Impact factor: 24.094

2.  Recessive arrhythmogenic right ventricular dysplasia due to novel cryptic splice mutation in PKP2.

Authors:  Mark M Awad; Darshan Dalal; Crystal Tichnell; Cynthia James; April Tucker; Theodore Abraham; Philip J Spevak; Hugh Calkins; Daniel P Judge
Journal:  Hum Mutat       Date:  2006-11       Impact factor: 4.878

3.  Arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in the desmosomal gene desmocollin-2.

Authors:  Petros Syrris; Deirdre Ward; Alison Evans; Angeliki Asimaki; Estelle Gandjbakhch; Srijita Sen-Chowdhry; William J McKenna
Journal:  Am J Hum Genet       Date:  2006-09-27       Impact factor: 11.025

Review 4.  Role of genetic analysis in the management of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy.

Authors:  Srijita Sen-Chowdhry; Petros Syrris; William J McKenna
Journal:  J Am Coll Cardiol       Date:  2007-10-24       Impact factor: 24.094

Review 5.  Mechanisms of disease: molecular genetics of arrhythmogenic right ventricular dysplasia/cardiomyopathy.

Authors:  Mark M Awad; Hugh Calkins; Daniel P Judge
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2008-04-01

6.  A missense variant in desmoglein-2 predisposes to dilated cardiomyopathy.

Authors:  Maximilian G Posch; Matthias J Posch; Christian Geier; Bettina Erdmann; Wolf Mueller; Anette Richter; Volker Ruppert; Sabine Pankuweit; Bernhard Maisch; Andreas Perrot; Jens Buttgereit; Rainer Dietz; Wilhelm Haverkamp; Cemil Ozcelik
Journal:  Mol Genet Metab       Date:  2008-08-03       Impact factor: 4.797

7.  A novel dominant mutation in plakoglobin causes arrhythmogenic right ventricular cardiomyopathy.

Authors:  Angeliki Asimaki; Petros Syrris; Thomas Wichter; Paul Matthias; Jeffrey E Saffitz; William J McKenna
Journal:  Am J Hum Genet       Date:  2007-09-28       Impact factor: 11.025

8.  Shared genetic causes of cardiac hypertrophy in children and adults.

Authors:  Hiroyuki Morita; Heidi L Rehm; Andres Menesses; Barbara McDonough; Amy E Roberts; Raju Kucherlapati; Jeffrey A Towbin; J G Seidman; Christine E Seidman
Journal:  N Engl J Med       Date:  2008-04-09       Impact factor: 91.245

9.  Comprehensive desmosome mutation analysis in north americans with arrhythmogenic right ventricular dysplasia/cardiomyopathy.

Authors:  A Dénise den Haan; Boon Yew Tan; Michelle N Zikusoka; Laura Ibañez Lladó; Rahul Jain; Amy Daly; Crystal Tichnell; Cynthia James; Nuria Amat-Alarcon; Theodore Abraham; Stuart D Russell; David A Bluemke; Hugh Calkins; Darshan Dalal; Daniel P Judge
Journal:  Circ Cardiovasc Genet       Date:  2009-06-03

10.  Desmoglein-2 and desmocollin-2 mutations in dutch arrhythmogenic right ventricular dysplasia/cardiomypathy patients: results from a multicenter study.

Authors:  Zahurul A Bhuiyan; Jan D H Jongbloed; Jasper van der Smagt; Paola M Lombardi; Ans C P Wiesfeld; Marcel Nelen; Meyke Schouten; Roselie Jongbloed; Moniek G P J Cox; Marleen van Wolferen; Luz M Rodriguez; Isabelle C van Gelder; Hennie Bikker; Albert J H Suurmeijer; Maarten P van den Berg; Marcel M A M Mannens; Richard N W Hauer; Arthur A M Wilde; J Peter van Tintelen
Journal:  Circ Cardiovasc Genet       Date:  2009-08-01
View more
  10 in total

1.  Unexplained cardiac arrest: a tale of conflicting interpretations of KCNQ1 genetic test results.

Authors:  Han Chow Chua; Helge Servatius; Babken Asatryan; André Schaller; Claudine Rieubland; Fabian Noti; Jens Seiler; Laurent Roten; Samuel H Baldinger; Hildegard Tanner; Juerg Fuhrer; Andreas Haeberlin; Anna Lam; Stephan A Pless; Argelia Medeiros-Domingo
Journal:  Clin Res Cardiol       Date:  2018-03-26       Impact factor: 5.460

2.  Patient mutations linked to arrhythmogenic cardiomyopathy enhance calpain-mediated desmoplakin degradation.

Authors:  Ronald Ng; Heather Manring; Nikolaos Papoutsidakis; Taylor Albertelli; Nicole Tsai; Claudia J See; Xia Li; Jinkyu Park; Tyler L Stevens; Prameela J Bobbili; Muhammad Riaz; Yongming Ren; Christopher E Stoddard; Paul Ml Janssen; T Jared Bunch; Stephen P Hall; Ying-Chun Lo; Daniel L Jacoby; Yibing Qyang; Nathan Wright; Maegen A Ackermann; Stuart G Campbell
Journal:  JCI Insight       Date:  2019-06-13

3.  GCN5 contributes to intracellular lipid accumulation in human primary cardiac stromal cells from patients affected by Arrhythmogenic cardiomyopathy.

Authors:  Chiara Volani; Alessandra Pagliaro; Johannes Rainer; Giuseppe Paglia; Benedetta Porro; Ilaria Stadiotti; Luisa Foco; Elisa Cogliati; Adolfo Paolin; Costanza Lagrasta; Caterina Frati; Emilia Corradini; Angela Falco; Theresa Matzinger; Anne Picard; Benedetta Ermon; Silvano Piazza; Marzia De Bortoli; Claudio Tondo; Réginald Philippe; Andrea Medici; Alexandros A Lavdas; Michael J F Blumer; Giulio Pompilio; Elena Sommariva; Peter P Pramstaller; Jakob Troppmair; Viviana Meraviglia; Alessandra Rossini
Journal:  J Cell Mol Med       Date:  2022-06-16       Impact factor: 5.295

4.  Incremental value of cardiac magnetic resonance imaging in arrhythmic risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers.

Authors:  Anneline S J M te Riele; Aditya Bhonsale; Cynthia A James; Neda Rastegar; Brittney Murray; Jeremy R Burt; Crystal Tichnell; Srinivasa Madhavan; Daniel P Judge; David A Bluemke; Stefan L Zimmerman; Ihab R Kamel; Hugh Calkins; Harikrishna Tandri
Journal:  J Am Coll Cardiol       Date:  2013-06-27       Impact factor: 24.094

5.  Sequenom MassARRAY approach in the arrhythmogenic right ventricular cardiomyopathy post-mortem setting: clinical and forensic implications.

Authors:  M Alcalde; O Campuzano; C Allegue; M Torres; E Arbelo; S Partemi; A Iglesias; J Brugada; A Oliva; A Carracedo; R Brugada
Journal:  Int J Legal Med       Date:  2014-05-16       Impact factor: 2.686

6.  Clinical phenotype and diagnosis of arrhythmogenic right ventricular cardiomyopathy in pediatric patients carrying desmosomal gene mutations.

Authors:  Barbara Bauce; Alessandra Rampazzo; Cristina Basso; Elisa Mazzotti; Ilaria Rigato; Alexandros Steriotis; Giorgia Beffagna; Alessandra Lorenzon; Marzia De Bortoli; Kalliopi Pilichou; Martina Perazzolo Marra; Francesco Corbetti; Luciano Daliento; Sabino Iliceto; Domenico Corrado; Gaetano Thiene; Andrea Nava
Journal:  Heart Rhythm       Date:  2011-06-30       Impact factor: 6.343

7.  Exercise has a disproportionate role in the pathogenesis of arrhythmogenic right ventricular dysplasia/cardiomyopathy in patients without desmosomal mutations.

Authors:  Abhishek C Sawant; Aditya Bhonsale; Anneline S J M te Riele; Crystal Tichnell; Brittney Murray; Stuart D Russell; Harikrishna Tandri; Ryan J Tedford; Daniel P Judge; Hugh Calkins; Cynthia A James
Journal:  J Am Heart Assoc       Date:  2014-12       Impact factor: 5.501

Review 8.  Mechanistic basis of desmosome-targeted diseases.

Authors:  Caezar Al-Jassar; Hennie Bikker; Michael Overduin; Martyn Chidgey
Journal:  J Mol Biol       Date:  2013-08-02       Impact factor: 5.469

9.  Case reports of two pedigrees with recessive arrhythmogenic right ventricular cardiomyopathy associated with homozygous Thr335Ala variant in DSG2.

Authors:  Sami Qadri; Olli Anttonen; Juho Viikilä; Eija H Seppälä; Samuel Myllykangas; Tero-Pekka Alastalo; Miia Holmström; Tiina Heliö; Juha W Koskenvuo
Journal:  BMC Med Genet       Date:  2017-08-17       Impact factor: 2.103

10.  The C-terminal unique region of desmoglein 2 inhibits its internalization via tail-tail interactions.

Authors:  Jing Chen; Oxana E Nekrasova; Dipal M Patel; Jodi L Klessner; Lisa M Godsel; Jennifer L Koetsier; Evangeline V Amargo; Bhushan V Desai; Kathleen J Green
Journal:  J Cell Biol       Date:  2012-11-05       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.